DeepMind's AlphaFold 3 identifies optimal drug combinations for individual cancer patients based on their genetic profile, leading to 80% higher remission rates in clinical trials.

OpenAI's latest language model demonstrates unprecedented reasoning abilities, solving complex mathematical proofs and writing code with minimal errors, raising both excitement and ethical concerns in the tech community.

After years of development and testing, Tesla receives regulatory approval for fully autonomous highway driving in California, marking a pivotal moment for the autonomous vehicle industry.